Federated Hermes
CLCD

Federated Hermes’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Federated Hermes’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-100
Closed -$4K – 2247
2016
Q4 		$4K Buy
+100
New +$3.54K ﹤0.01% 1983

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Federated Hermes's CLCD Position: Q1 2017 in Review

Federated Hermes sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 100 shares — an estimated $4K sold.

Federated Hermes first reported a position in CLCD in Q4 2016 and held it in 1 quarter. The position peaked at $4K in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Federated Hermes reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Federated Hermes sold 100 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $4K.
  • Federated Hermes first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
  • Federated Hermes's CoLucid Pharmaceuticals, Inc. position peaked at $4K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Federated Hermes's 13F filing for Q1 2017, filed 12 May 2017.